Leucine Zipper, Putative Tumor Suppressor 1 (LZTS1) (C-Term) Peptide
LZTS1
Reactivité: Souris
Hôte: Synthetic
BP, WB
-
- Antigène Tous les produits LZTS1
- LZTS1 (Leucine Zipper, Putative Tumor Suppressor 1 (LZTS1))
- Protein Region
- C-Term
- Origine
- Souris
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Séquence
- HERLVWKEEK EKVIQYQRQL QQSYLAMYQR NQRLEKALQQ LARGDGPGEP
- Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-Lzts1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Antigène
- LZTS1 (Leucine Zipper, Putative Tumor Suppressor 1 (LZTS1))
- Synonymes
- F37 Peptide, FEZ1 Peptide, Psdzip70 Peptide, LZTS1 Peptide, f37 Peptide, fez1 Peptide, leucine zipper tumor suppressor 1 Peptide, leucine zipper, putative tumor suppressor 1 Peptide, LZTS1 Peptide, Lzts1 Peptide, lzts1 Peptide
- Sujet
-
Lzts1 is involved in the regulation of cell growth. It may stabilize the active CDC2-cyclin B1 complex and thereby contribute to the regulation of the cell cycle and the prevention of uncontrolled cell proliferation. It may act as tumor suppressor.
Alias Symbols: F37, FEZ1
Protein Size: 599 - Poids moléculaire
- 67 kDa
- ID gène
- 211134
- NCBI Accession
- NM_199364, NP_955396
- UniProt
- P60853
-
Vous êtes ici:
